Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,812.00    -16.00 (-0.57%)
Bid:
2,810.00
Ask:
2,814.00
Spread: 4.00 (0.142%)
Market Cap: £6.69b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Director/PDMR Shareholding

13 Aug 2014 15:34

RNS Number : 0711P
IMI PLC
13 August 2014
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4.

Β 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

Β 

Please complete all relevant boxes in block capital letters.

Β 

1. Name of the issuer

Β 

IMI plc

Β 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R,; (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006)

Β 

Disclosure relates to point (i)

Β 

3. Name of person discharging managerial responsibilities/director

Mark Selway

-

Chief Executive

Douglas Hurt

-

Finance Director

Roy Twite

-

Divisional Managing Director, Critical Engineering

Paul Roberts

-

Group Business Development Director

Β 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

N/A

Β 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

Β 

Notification in respect of persons named in 3 above

Β 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

Ordinary Shares of 28 4/7p each

Β 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Β 

Mark Selway

-

8,765

Douglas Hurt

-

188,933

Roy Twite

-

117,237

Paul Roberts

-

7,094

Β 

8. State the nature of the transaction

Β 

Shares purchased pursuant to participation in the IMI Employee Share Ownership Plan

Β 

9. Number of shares, debentures or financial instruments relating to shares acquired

Β 

Mark Selway

-

10

Douglas Hurt

-

9

Roy Twite

-

9

Paul Roberts

-

9

Β 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

Mark Selway

-

0.000004%

Douglas Hurt

-

0.000003%

Roy Twite

-

0.000003%

Paul Roberts

-

0.000003%

Β 

11. Number of shares, debentures or financial instruments relating to shares disposed

Β 

N/A

Β 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)Β 

Β 

N/A

Β 

13. Price pershare or value of transaction

Β 

Β£13.67

Β 

14. Date and place of transaction

Β 

12 August 2014, London

Β 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

Mark Selway

8,775

-

0.003%

Douglas Hurt

Β 188,942

-

0.07%

Roy Twite

Β 117,246

-

0.04%

Paul Roberts

7,103

-

0.003%

Β 

16. Date issuer informed of transaction

Β 

13 August 2014

Β 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

Β 

17. Date of grant

Β 

N/A

Β 

18. Period during which or date on which exercisable

Β 

N/A

Β 

19. Total amount paid (if any) for grant of the option

Β 

N/A

Β 

20. Description of shares or debentures involved (class and number)

Β 

N/A

Β 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Β 

N/A

Β 

22. Total number of shares or debentures over which options held following notification

Β 

N/A

Β 

23. Any additional information

Β 

N/A

Β 

24. Name of contact and telephone number for queries

Β 

H Afford - Senior Corporate Counsel - 0121 717 3700

Β 

Name of authorised official of issuer responsible for making notification

Β 

H Afford - Senior Corporate Counsel

Β 

Date of notification

Β 

13 August 2014

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSSFDFLDFLSEDA
Date   Source Headline
10th Jan 20241:01 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:35 amRNSBlock listing Interim Review
2nd Jan 202411:04 amRNSTotal Voting Rights
19th Dec 20239:55 amRNSDirector/PDMR Shareholding
13th Dec 20233:41 pmRNSDirector/PDMR Shareholding
5th Dec 20239:28 amRNSDirector Declaration
1st Dec 20231:30 pmRNSTotal Voting Rights
15th Nov 20231:42 pmRNSDirector/PDMR Shareholding
9th Nov 20237:01 amRNSHistorical Financial Information
9th Nov 20237:00 amRNSInterim Management Statement
1st Nov 202312:42 pmRNSTotal Voting Rights
11th Oct 20233:20 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:19 pmRNSTotal Voting Rights
13th Sep 20233:32 pmRNSDirector/PDMR Shareholding
1st Sep 202311:29 amRNSTotal Voting Rights
10th Aug 20234:53 pmRNSDirector/PDMR Shareholding
10th Aug 20234:38 pmRNSDirector/PDMR Shareholding
9th Aug 20232:34 pmRNSDirector/PDMR Shareholding
1st Aug 202310:16 amRNSTotal Voting Rights
31st Jul 20231:52 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSInterim Results
12th Jul 20231:13 pmRNSDirector/PDMR Shareholding
3rd Jul 20232:58 pmRNSBlock listing Interim Review
3rd Jul 20232:41 pmRNSTotal Voting Rights
26th Jun 20234:39 pmRNSHolding(s) in Company
14th Jun 202310:48 amRNSDirector/PDMR Shareholding
8th Jun 20233:18 pmRNSDirector/PDMR Shareholding
1st Jun 20231:51 pmRNSTotal Voting Rights
22nd May 202310:18 amRNSDirectorate Change
11th May 202311:49 amRNSHolding(s) in Company
10th May 20232:40 pmRNSDirector/PDMR Shareholding
4th May 20231:05 pmRNSResult of AGM
4th May 20237:00 amRNSInterim Management Statement
2nd May 20232:46 pmRNSTotal Voting Rights
14th Apr 20233:18 pmRNSDirector/PDMR Shareholding
12th Apr 202311:29 amRNSDirector/PDMR Shareholding
3rd Apr 202311:38 amRNSTotal Voting Rights
29th Mar 20234:53 pmRNSHolding(s) in Company
27th Mar 202311:35 amRNSDirector/PDMR Shareholding
27th Mar 202311:25 amRNSDirector/PDMR Shareholding
24th Mar 20239:49 amRNSAnnual Financial Report
16th Mar 20239:28 amRNSHolding(s) in Company
15th Mar 20232:13 pmRNSDirector/PDMR Shareholding
8th Mar 20233:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSPreliminary Results
1st Mar 20231:36 pmRNSTotal Voting Rights
15th Feb 202312:43 pmRNSDirector/PDMR Shareholding
1st Feb 202312:39 pmRNSTotal Voting Rights
26th Jan 202311:00 amRNSHolding(s) in Company
19th Jan 202310:07 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.